Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
An opioid is a synthetic or natural agent that stimulates opioid receptors and produces opium-like effects. Opioid use disorder is a problematic pattern of opioid use that causes significant impairment or distress.
Increase in opioid epidemic in the U.S. coupled with establishment of government policies to control the crisis is driving the market.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Opioid Use Disorder market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Opioid Use Disorder market. Detailed analysis of key players, along with key growth strategies adopted by Opioid Use Disorder industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Teva Pharmaceuticals
Alkermes
Omeros
BioDelivery Sciences International Inc
Pfizer, Inc
Orexo
Mallinckrodt Pharmaceuticals
Hikma Pharmaceuticals
Camurus
Indivior
Titan Pharmaceuticals
MediciNova
By Type:
Buprenorphine
Methadone
Naltrexone
By End-User:
Severe Pain Treatment
Moderate Pain Treatment
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Opioid Use Disorder Market
-
1.3 Market Segment by Type
-
1.3.1 USA Opioid Use Disorder Market Size and Growth Rate of Buprenorphine from 2016 to 2027
-
1.3.2 USA Opioid Use Disorder Market Size and Growth Rate of Methadone from 2016 to 2027
-
1.3.3 USA Opioid Use Disorder Market Size and Growth Rate of Naltrexone from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Opioid Use Disorder Market Size and Growth Rate of Severe Pain Treatment from 2016 to 2027
-
1.4.2 USA Opioid Use Disorder Market Size and Growth Rate of Moderate Pain Treatment from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Opioid Use Disorder Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Opioid Use Disorder Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Opioid Use Disorder Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Opioid Use Disorder Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Opioid Use Disorder Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Opioid Use Disorder by Major Types
-
3.4.1 Market Size and Growth Rate of Buprenorphine
-
3.4.2 Market Size and Growth Rate of Methadone
-
3.4.3 Market Size and Growth Rate of Naltrexone
4 Segmentation of Opioid Use Disorder Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Opioid Use Disorder by Major End-Users
-
4.4.1 Market Size and Growth Rate of Opioid Use Disorder in Severe Pain Treatment
-
4.4.2 Market Size and Growth Rate of Opioid Use Disorder in Moderate Pain Treatment
5 Market Analysis by Regions
-
5.1 USA Opioid Use Disorder Production Analysis by Regions
-
5.2 USA Opioid Use Disorder Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Opioid Use Disorder Landscape Analysis
-
6.1 West USA Opioid Use Disorder Landscape Analysis by Major Types
-
6.2 West USA Opioid Use Disorder Landscape Analysis by Major End-Users
7 South USA Opioid Use Disorder Landscape Analysis
-
7.1 South USA Opioid Use Disorder Landscape Analysis by Major Types
-
7.2 South USA Opioid Use Disorder Landscape Analysis by Major End-Users
8 Middle West USA Opioid Use Disorder Landscape Analysis
-
8.1 Middle West USA Opioid Use Disorder Landscape Analysis by Major Types
-
8.2 Middle West USA Opioid Use Disorder Landscape Analysis by Major End-Users
9 Northeast USA Opioid Use Disorder Landscape Analysis
-
9.1 Northeast USA Opioid Use Disorder Landscape Analysis by Major Types
-
9.2 Northeast USA Opioid Use Disorder Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Teva Pharmaceuticals
-
10.1.1 Teva Pharmaceuticals Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Alkermes
-
10.2.1 Alkermes Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Omeros
-
10.3.1 Omeros Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 BioDelivery Sciences International Inc
-
10.4.1 BioDelivery Sciences International Inc Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Pfizer, Inc
-
10.5.1 Pfizer, Inc Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Orexo
-
10.6.1 Orexo Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Mallinckrodt Pharmaceuticals
-
10.7.1 Mallinckrodt Pharmaceuticals Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Hikma Pharmaceuticals
-
10.8.1 Hikma Pharmaceuticals Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Camurus
-
10.9.1 Camurus Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Indivior
-
10.10.1 Indivior Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Titan Pharmaceuticals
-
10.11.1 Titan Pharmaceuticals Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 MediciNova
-
10.12.1 MediciNova Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Opioid Use Disorder Market Size and Growth Rate of Buprenorphine from 2016 to 2027
-
Figure USA Opioid Use Disorder Market Size and Growth Rate of Methadone from 2016 to 2027
-
Figure USA Opioid Use Disorder Market Size and Growth Rate of Naltrexone from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Opioid Use Disorder Market Size and Growth Rate of Severe Pain Treatment from 2016 to 2027
-
Figure USA Opioid Use Disorder Market Size and Growth Rate of Moderate Pain Treatment from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Opioid Use Disorder Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Opioid Use Disorder Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Opioid Use Disorder Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Opioid Use Disorder Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Opioid Use Disorder Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Opioid Use Disorder
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Opioid Use Disorder by Different Types from 2016 to 2027
-
Table Consumption Share of Opioid Use Disorder by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Buprenorphine
-
Figure Market Size and Growth Rate of Methadone
-
Figure Market Size and Growth Rate of Naltrexone
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Opioid Use Disorder by Different End-Users from 2016 to 2027
-
Table Consumption Share of Opioid Use Disorder by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Severe Pain Treatment
-
Figure Market Size and Growth Rate of Moderate Pain Treatment
-
Table USA Opioid Use Disorder Production by Regions
-
Table USA Opioid Use Disorder Production Share by Regions
-
Figure USA Opioid Use Disorder Production Share by Regions in 2016
-
Figure USA Opioid Use Disorder Production Share by Regions in 2021
-
Figure USA Opioid Use Disorder Production Share by Regions in 2027
-
Table USA Opioid Use Disorder Consumption by Regions
-
Table USA Opioid Use Disorder Consumption Share by Regions
-
Figure USA Opioid Use Disorder Consumption Share by Regions in 2016
-
Figure USA Opioid Use Disorder Consumption Share by Regions in 2021
-
Figure USA Opioid Use Disorder Consumption Share by Regions in 2027
-
Table West USA Opioid Use Disorder Consumption by Types from 2016 to 2027
-
Table West USA Opioid Use Disorder Consumption Share by Types from 2016 to 2027
-
Figure West USA Opioid Use Disorder Consumption Share by Types in 2016
-
Figure West USA Opioid Use Disorder Consumption Share by Types in 2021
-
Figure West USA Opioid Use Disorder Consumption Share by Types in 2027
-
Table West USA Opioid Use Disorder Consumption by End-Users from 2016 to 2027
-
Table West USA Opioid Use Disorder Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Opioid Use Disorder Consumption Share by End-Users in 2016
-
Figure West USA Opioid Use Disorder Consumption Share by End-Users in 2021
-
Figure West USA Opioid Use Disorder Consumption Share by End-Users in 2027
-
Table South USA Opioid Use Disorder Consumption by Types from 2016 to 2027
-
Table South USA Opioid Use Disorder Consumption Share by Types from 2016 to 2027
-
Figure South USA Opioid Use Disorder Consumption Share by Types in 2016
-
Figure South USA Opioid Use Disorder Consumption Share by Types in 2021
-
Figure South USA Opioid Use Disorder Consumption Share by Types in 2027
-
Table South USA Opioid Use Disorder Consumption by End-Users from 2016 to 2027
-
Table South USA Opioid Use Disorder Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Opioid Use Disorder Consumption Share by End-Users in 2016
-
Figure South USA Opioid Use Disorder Consumption Share by End-Users in 2021
-
Figure South USA Opioid Use Disorder Consumption Share by End-Users in 2027
-
Table Middle West USA Opioid Use Disorder Consumption by Types from 2016 to 2027
-
Table Middle West USA Opioid Use Disorder Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Opioid Use Disorder Consumption Share by Types in 2016
-
Figure Middle West USA Opioid Use Disorder Consumption Share by Types in 2021
-
Figure Middle West USA Opioid Use Disorder Consumption Share by Types in 2027
-
Table Middle West USA Opioid Use Disorder Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Opioid Use Disorder Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Opioid Use Disorder Consumption Share by End-Users in 2016
-
Figure Middle West USA Opioid Use Disorder Consumption Share by End-Users in 2021
-
Figure Middle West USA Opioid Use Disorder Consumption Share by End-Users in 2027
-
Table Northeast USA Opioid Use Disorder Consumption by Types from 2016 to 2027
-
Table Northeast USA Opioid Use Disorder Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Opioid Use Disorder Consumption Share by Types in 2016
-
Figure Northeast USA Opioid Use Disorder Consumption Share by Types in 2021
-
Figure Northeast USA Opioid Use Disorder Consumption Share by Types in 2027
-
Table Northeast USA Opioid Use Disorder Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Opioid Use Disorder Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Opioid Use Disorder Consumption Share by End-Users in 2016
-
Figure Northeast USA Opioid Use Disorder Consumption Share by End-Users in 2021
-
Figure Northeast USA Opioid Use Disorder Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Teva Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Teva Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Teva Pharmaceuticals
-
Table Product and Service Introduction of Teva Pharmaceuticals
-
Table Company Profile and Development Status of Alkermes
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alkermes
-
Figure Sales and Growth Rate Analysis of Alkermes
-
Figure Revenue and Market Share Analysis of Alkermes
-
Table Product and Service Introduction of Alkermes
-
Table Company Profile and Development Status of Omeros
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Omeros
-
Figure Sales and Growth Rate Analysis of Omeros
-
Figure Revenue and Market Share Analysis of Omeros
-
Table Product and Service Introduction of Omeros
-
Table Company Profile and Development Status of BioDelivery Sciences International Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioDelivery Sciences International Inc
-
Figure Sales and Growth Rate Analysis of BioDelivery Sciences International Inc
-
Figure Revenue and Market Share Analysis of BioDelivery Sciences International Inc
-
Table Product and Service Introduction of BioDelivery Sciences International Inc
-
Table Company Profile and Development Status of Pfizer, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer, Inc
-
Figure Sales and Growth Rate Analysis of Pfizer, Inc
-
Figure Revenue and Market Share Analysis of Pfizer, Inc
-
Table Product and Service Introduction of Pfizer, Inc
-
Table Company Profile and Development Status of Orexo
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Orexo
-
Figure Sales and Growth Rate Analysis of Orexo
-
Figure Revenue and Market Share Analysis of Orexo
-
Table Product and Service Introduction of Orexo
-
Table Company Profile and Development Status of Mallinckrodt Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Mallinckrodt Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Mallinckrodt Pharmaceuticals
-
Table Product and Service Introduction of Mallinckrodt Pharmaceuticals
-
Table Company Profile and Development Status of Hikma Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hikma Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Hikma Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Hikma Pharmaceuticals
-
Table Product and Service Introduction of Hikma Pharmaceuticals
-
Table Company Profile and Development Status of Camurus
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Camurus
-
Figure Sales and Growth Rate Analysis of Camurus
-
Figure Revenue and Market Share Analysis of Camurus
-
Table Product and Service Introduction of Camurus
-
Table Company Profile and Development Status of Indivior
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Indivior
-
Figure Sales and Growth Rate Analysis of Indivior
-
Figure Revenue and Market Share Analysis of Indivior
-
Table Product and Service Introduction of Indivior
-
Table Company Profile and Development Status of Titan Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Titan Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Titan Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Titan Pharmaceuticals
-
Table Product and Service Introduction of Titan Pharmaceuticals
-
Table Company Profile and Development Status of MediciNova
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of MediciNova
-
Figure Sales and Growth Rate Analysis of MediciNova
-
Figure Revenue and Market Share Analysis of MediciNova
-
Table Product and Service Introduction of MediciNova
-
